Director/PDMR Shareholding

Deltex Medical Group PLC
29 June 2007


                            Deltex Medical Group plc

                                Grant of options

Deltex Medical Group plc ('Deltex Medical' or 'Company'), the UK's leading
haemodynamic monitoring company, today announces that the Board has approved the
issue of share options to Andy Hill, Chief Executive, and Ewan Phillips, Finance
Director, under the Company's 2003 Enterprise Management Incentive Scheme ('EMI
Scheme'). This scheme allows the directors concerned to sacrifice their
entitlement to cash bonuses in return for share options at the nominal value of
1p per share. The details are as follows:

                                  Exercise           Exercise        Exercise 
Name            No. of options     Price £        period from        period to

Andy Hill              314,615        0.01       See note (a)     28 June 2017
Ewan Phillips          235,962        0.01       See note (a)     28 June 2017


Note (a). Date of release of preliminary results for the year ended 31 December
2007.

In addition, the Board has also approved the issue of contractual share options
to Andy Hill, Chief Executive and Ewan Phillips, Finance Director under the
Company's 2001 Executive Share Option Scheme.

                                   Exercise          Exercise        Exercise 
Name            No. of options      Price £       period from        period to

Andy Hill          400,000            0.295      29 June 2010     28 June 2017
Ewan Phillips      400,000            0.295      29 June 2010     28 June 2017


In addition to the options outlined above, Andy Hill has an interest in the
following:

                                   Exercise          Exercise         Exercise 
Name            No. of options      Price £       period from        period to

Executive Share 
Option Scheme

                       200,000         0.25  27 November 2005 26 November 2012
                       200,000         0.15   28 October 2006  27 October 2013
                       400,000         0.24   12 October 2007  11 October 2014
                       400,000       0.2075     28 March 2009    27 March 2016

EMI Scheme             333,333         0.01     24 March 2004  27 October 2013
                       156,739         0.01     15 March 2005  11 October 2014
                       154,085         0.01     15 March 2007      19 May 2016

In addition to the options outlined above, Ewan Phillips has an interest in the
following:


                                   Exercise          Exercise         Exercise 
Name            No. of options      Price £       period from        period to
Executive Share 
Option Scheme

                       100,000         0.25   7 November 2004  6 November 2011
                       60,000          0.25  27 November 2005 26 November 2012
                       120,000         0.15   28 October 2006  27 October 2013
                       400,000         0.24   12 October 2007  11 October 2014
                       400,000       0.2075     28 March 2009    27 March 2016

EMI Scheme             583,333         0.01     24 March 2004  27 October 2013
                       156,739         0.01     15 March 2005  11 October 2014
                       259,225         0.01     15 March 2007      19 May 2016

Andy Hill also has a beneficial interest in 179,334 ordinary shares in the
Company representing 0.19 per cent of the Company's issued ordinary share
capital.

Ewan Phillips also has a beneficial interest in 917,156 ordinary shares in the
Company representing 0.99 per cent of the Company's issued ordinary share
capital.

All shares and options relate to 1p ordinary shares.

29 June 2007

Enquiries:

Deltex Medical Group plc                                01243 774 837
Nigel Keen, Chairman
Andy Hill, Chief Executive
Ewan Phillips, Finance Director

Charles Stanley Securities (Nominated Adviser)          0207 149 6000

Philip Davies / Carl Holmes

Gavin Anderson
Deborah Walter/Marie Cairney/Jodie Reilly               0207 554 1400


                      This information is provided by RNS
            The company news service from the London Stock Exchange